📋 Tender Overview
The DAK-Gesundheit intends to conclude non-exclusive discount agreements for the specified active ingredient, allergen extract from meadow fescue, smoke grass, meadow knapweed, ryegrass, and meadow rice grass pollen, ATC V01AA02, with interested pharmaceutical companies until the new drug discount agreements come into effect. The agreements will be established through a formal procurement process according to the regulations of the GWB. The contracts will commence on October 1, 2026, and end on September 30, 2028. Allergen extract from meadow fescue, smoke grass, meadow knapweed, ryegrass, and meadow rice grass pollen, ATC V01AA02